NEW SITE — FASTER TURNAROUND, MORE LABS. READ ON
Peptide testing

Ordered BPC-157 from LiliPeptide? Mail in a sample (US only) and let us test it.

Test my supply
+7 more ↓
68%
Finnrick rating
#2 of 149 BPC-157 vendors
18 of 24 classifiable tests passed
natural 75% · customers 4.3★ (26)
methodology · Purity focus
Finnrick analysis · BPC-157

LiliPeptide BPC-157 is held back by a recent identity failure with 0 mg and 0% purity, interrupting an improving run after winter purity misses. The key detail is whether the listed March 11 batch anomaly is isolated despite nearby passes.

methodology →
vendor intelligence report
Vendor Intelligence Report: LiliPeptide

Corporate and domain records point to a China/Hong Kong sales network behind the U.S.-listed storefront, with the typo domain, Peptide-Sources and ElitePeptide66 tied by reused policy text. The report maps batchless COAs, Nuoao template artifacts and post-payment fee complaints.

37 pages8 risk factors assessed12 Nov 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
GHK-Cu
$0.06
94%
28
2
Tirzepatide
$0.53
82%
44
3
Retatrutide
$0.97
80%
157
4
SS-31
$1.15
77%
3
5
PT-141
$0.40
69%
10
6
BPC-157selected
$0.70
68%
24
7
Ipamorelin
$0.95
64%
10
8
Tesamorelin
$2.45
56%
24
9
Melanotan II
$0.55
56%
5
10
Cagrilintide
$25.00
54%
4
11
CJC-IPA
-
44%
1
12
MOTS-c
$0.80
37%
9
13
NAD+
$0.02
26%
4
14
CJC-1295
$2.05
25%
6
15
TB-500
$1.55
22%
15
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%26 Jan 2026: 50%9 Feb 2026: 52%20 Feb 2026: 56%18 Mar 2026: 59%18 Mar 2026: 61%18 Mar 2026: 63%18 Mar 2026: 65%21 Mar 2026: 67%13 May 2026: 68%1 Jun 2026: 70%2 Jun 2026: 71%17 Jun 2026: 69%24 Jun 2026: 70%9 Sep 2026: 71%16 Sep 2026: 68%15 Nov 2026: current 68%50%68%68%Jan 26Nov 26
Showing BPC-157 tests only
Peptide testing

Ordered BPC-157 from LiliPeptide? Mail in a sample (US only) and let us test it.

Test my supply
LiliPeptide BPC-157 test history
COA-backed lab tests
1-10 of 24

About LiliPeptide test results from Finnrick

LiliPeptide is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 15 peptides and 344 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible LiliPeptide peptides in this dataset are BPC-157 (24 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 200 recent tests.

Corrections
No corrections.
Peptide testing

Ordered BPC-157 from LiliPeptide? Mail in a sample (US only) and let us test it.

Test my supply